Literature DB >> 30711778

Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease.

Erica Stohs1, Victor A Chow2, Catherine Liu3, Lori Bourassa4, Arianna Miles-Jay5, Julie Knight6, Ania Sweet7, Barry E Storer8, Marco Mielcarek2, Steven A Pergam9.   

Abstract

Steroids used to treat acute graft-versus-host-disease (GVHD) are believed to blunt clinical symptoms of infection. We aimed to assess the value of weekly surveillance blood cultures (SBCs) drawn in an outpatient setting from hematopoietic cell transplant (HCT) patients receiving high-dose steroids. We hypothesized that most positive outpatient surveillance cultures would be low-pathogenicity, gram-positive organisms and would lead to excess vancomycin therapy. We conducted a retrospective review of blood cultures collected from a cohort of adult HCT patients enrolled in a clinical trial of acute GVHD therapy with high-dose steroids (prednisone-equivalent doses ≥ .5 mg/kg/day) between April 2009 and May 2013. SBCs were defined as those collected weekly from central venous catheters in the outpatient setting while patients were receiving high-dose steroids. Cultures obtained as part of a symptom workup or as follow-up for documented bacteremia were excluded. Clinical data were collected using center databases supplemented by medical record review. One hundred twenty-seven HCT recipients were eligible for inclusion in the study. A total of 1015 SBCs were obtained, with a median of 8 cultures (interquartile range, 5 to 10) per patient. Forty-two organisms were isolated from 36 of 1015 cultures (3.5%) in 30 unique patients, or 1 positive culture per 28 blood cultures drawn. The most frequently detected organisms were coagulase-negative Staphylococci (25/1015 [2.5%]). Gram-negative organisms were rare (4/1015 [.4%]. Antibiotics were administered to most patients with positive surveillance cultures (33/36 [92%]). Six were admitted to the hospital for treatment; none needed intensive care or died from their bacteremia. Vancomycin was the most frequently administered antibiotic, comprising 256 of 376 total days (68%) of antibiotic received by the cohort with a median duration of 10 days ((interquartile range, 7 to 14). Weekly outpatient SBCs obtained from asymptomatic patients on high-dose glucocorticoids for treatment of acute GVHD after allogeneic HCT were infrequently positive, and most organisms were low-pathogenicity organisms. SBCs also led to excess antibiotic exposure and costs, suggesting benefits of such ambulatory screening may be of limited value in this setting.
Copyright © 2019 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Glucocorticoids; Graft-versus-host disease; Infectious diseases; Surveillance

Mesh:

Substances:

Year:  2019        PMID: 30711778      PMCID: PMC6559865          DOI: 10.1016/j.bbmt.2019.01.031

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  25 in total

1.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  High incidence of bloodstream infection detected by surveillance blood cultures in hematology patients on corticosteroid therapy.

Authors:  A Joosten; J Maertens; J Verhaegen; T Lodewyck; E Vermeulen; K Lagrou
Journal:  Support Care Cancer       Date:  2012-08-09       Impact factor: 3.603

3.  Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients.

Authors:  Steven A Pergam; Hu Xie; Ravinder Sandhu; Margaret Pollack; Jeremy Smith; Terry Stevens-Ayers; Valeria Ilieva; Louise E Kimball; Meei-Li Huang; Tracy S Hayes; Lawrence Corey; Michael J Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-03       Impact factor: 5.742

4.  Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.

Authors:  Marco Mielcarek; Terrence Furlong; Barry E Storer; Margaret L Green; George B McDonald; Paul A Carpenter; Mary E D Flowers; Rainer Storb; Michael Boeckh; Paul J Martin
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

5.  Value of surveillance blood cultures in neutropenic patients--a pilot study.

Authors:  Olaf Penack; Ullrich Keilholz; Eckhard Thiel; Igor Wolfgang Blau
Journal:  Jpn J Infect Dis       Date:  2005-06       Impact factor: 1.362

6.  Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

Authors:  Malgorzata Mikulska; Valerio Del Bono; Anna Maria Raiola; Barbara Bruno; Francesca Gualandi; Domenico Occhini; Carmen di Grazia; Francesco Frassoni; Andrea Bacigalupo; Claudio Viscoli
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

7.  Routine surveillance for bloodstream infections in a pediatric hematopoietic stem cell transplant cohort: Do patients benefit?

Authors:  Heather Rigby; Conrad V Fernandez; Joanne Langley; Tim Mailman; Bruce Crooks; Ann Higgins
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 8.  Microbial ecology of the skin.

Authors:  R R Roth; W D James
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

9.  Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.

Authors:  M-A Colombier; M Lafaurie; F S de Fontbrune; M Resche-Rigon; J-L Donay; J-L Pons; J-M Molina; G Socie
Journal:  Transpl Infect Dis       Date:  2016-08-01       Impact factor: 2.228

10.  Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation.

Authors:  Sameeh S Ghazal; Michael P Stevens; Gonzalo M Bearman; Michael B Edmond
Journal:  Antimicrob Resist Infect Control       Date:  2014-06-04       Impact factor: 4.887

View more
  3 in total

1.  Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections.

Authors:  Margaret L Lind; Amanda I Phipps; Stephen Mooney; Catherine Liu; Alison Fohner; Kevin Patel; Masumi Ueda; Steven A Pergam
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 20.999

2.  Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  Boris Böll; Enrico Schalk; Dieter Buchheidt; Justin Hasenkamp; Michael Kiehl; Til Ramon Kiderlen; Matthias Kochanek; Michael Koldehoff; Philippe Kostrewa; Annika Y Claßen; Sibylle C Mellinghoff; Bernd Metzner; Olaf Penack; Markus Ruhnke; Maria J G T Vehreschild; Florian Weissinger; Hans-Heinrich Wolf; Meinolf Karthaus; Marcus Hentrich
Journal:  Ann Hematol       Date:  2020-09-30       Impact factor: 3.673

3.  Are hematopoietic cell transplant recipients with Gram-negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center.

Authors:  Margaret L Lind; Steven Roncaioli; Catherine Liu; Andrew Bryan; Ania Sweet; Frank Tverdek; Mohamed Sorror; Amanda I Phipps; Steven A Pergam
Journal:  Immun Inflamm Dis       Date:  2021-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.